Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis

<div>Enrichment analysis of DEGs. (a) GO analysis: top 5 of biological processes (BP), cellular components (CC), and molecular function (MF). (b) Pathway analysis: top 5 KEGG pathways and Reactome pathways.</div>

Disease Markers

fig2

Figure 2

Figure 2: Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis 